Given these mechanisms, liquid biopsy markers, such as CA15-3 (MUC1) and CA125 (MUC16) have demonstrated strong diagnostic potential in breast cancer and ovarian cancer (84–86). This evidence concerns the gene MUC16 and breast carcinoma.